We uncovered RBM39 as a new splicing activator and RBM10 as a splicing suppressor of RAC1B in LUAD, which greatly facilitates the understanding of RAC1B splicing regulation and functional significance in cancer. This evidence concerns the gene RBM39 and cancer.